Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 193Lung Neoplasms 80Pancreatic Neoplasms 47Neoplasms 31Non-Squamous Non-Small Cell Lung Cancer 19Head and Neck Neoplasms 19Glioblastoma 19Adenocarcinoma of Lung 19Squamous Cell Carcinoma of Head and Neck 18Neoplasm Metastasis 17Gliosarcoma 17Brain Neoplasms 17Breast Neoplasms 16Rectal Neoplasms 13Colorectal Neoplasms 13Colonic Neoplasms 13Adenocarcinoma, Bronchiolo-Alveolar 13Carcinoma, Hepatocellular 11Carcinoma, Renal Cell 10Glioma 8Astrocytoma 8Salivary Gland Neoplasms 7Gallbladder Neoplasms 7Esophageal Neoplasms 7Carcinoma, Ovarian Epithelial 7Prostatic Neoplasms 6Ovarian Neoplasms 6Oligodendroglioma 6Fallopian Tube Neoplasms 6Carcinoma, Squamous Cell 6

Interventions

Cisplatin 4Pemetrexed 3Chemotherapy, Adjuvant 3cediranib 2Radiotherapy 2Neoadjuvant Therapy 2Gemcitabine 2vatalanib 1pembrolizumab 1belinostat 1Watchful Waiting 1Vinorelbine 1Talc 1Sorafenib 1Semaxinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Methotrexate 1Gefitinib 1Erlotinib Hydrochloride 1Dihematoporphyrin Ether 1Dasatinib 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Solitary Fibrous Tumor, Pleural × Erlotinib Hydrochloride × Clear all
NCT00039182 2013-01-24

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

National Cancer Institute (NCI)

Phase 2 Completed
55 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡